Simafex is subsidiary of the French pharmaceutical Guerbet Group, one of the world’s leading medical imaging specialists. Over the last decades, Simafex has acquired experience in the field of fine chemicals and is specialized in custom synthesis for advanced intermediates and active pharmaceutical ingredients from the laboratory to industrial scale production for the pharmaceutical industry. Simafex has developped a pharmaceutical culture in conformity with the full range of international quality requirements. Simafex was successfully inspected by the FDA in 2011 and 2013 and ANSM (the French health authority). Simafex has been accredited with the Japanese authorities since 2009 for the commercialization of an injectable API.